Literature DB >> 29124406

Selective lateral pelvic lymph node dissection: a comparative study of the robotic versus laparoscopic approach.

Hye Jin Kim1, Gyu-Seog Choi2, Jun Seok Park1, Soo Yeun Park1, Hee Jae Lee1, In Taek Woo1, In Kyu Park1.   

Abstract

BACKGROUND: Lateral pelvic lymph node dissection (LPND) is a challenging procedure due to its technical difficulty and higher incidence of surgical morbidity. We compared short-term outcomes between laparoscopic and robotic LPND in patients with rectal cancer.
METHODS: Between May 2006 and December 2014, prospectively collected data from consecutive patients undergoing robotic or laparoscopic total mesorectal excision (TME) with LPND were retrospectively compared. Patients' demographics, perioperative outcomes, functional results, and initial oncologic outcomes were analyzed.
RESULTS: Fifty and 35 patients underwent robotic or laparoscopic TME with LPND, respectively. Bilateral LPND was performed in 10 patients (20%) in the robotic group and 6 (17.1%) in the laparoscopic group. For unilateral pelvic dissection, the mean operative time was not significantly different between groups (robotic vs. laparoscopic group, 41.0 ± 15.8 min vs. 35.3 ± 13.4 min; P = 0.146), but the EBL was significantly lower in the robotic group (34.6 ± 21.9 mL vs. 50.6 ± 23.8 mL; P = 0.002). Two patients (4.0%) in the robotic group and 7 (20.0%) in the laparoscopic group underwent Foley catheter reinsertion for urinary retention postoperatively (P = 0.029). The mean number of harvested lateral pelvic lymph nodes (LPNs) was 6.6 (range 0-25) in the robotic group and 6.4 (range 1-14) in the laparoscopic group. Pathologic LPN metastatic rate was not different between groups (robotic vs. laparoscopic group, 28.0 vs. 41.2%; P = 0.243). During the median follow-up of 26.3 months, overall recurrence rate was not different between groups (robotic vs. laparoscopic group, 30.0 vs. 31.2%; P = 0.850). Three patients (6.0%) in the robotic group and 4 (11.4%) in the laparoscopic group developed local recurrence (P = 0.653).
CONCLUSIONS: Robotic TME with LPND is safe and feasible with favorable short-term surgical outcomes.

Entities:  

Keywords:  Laparoscopic surgery; Lateral pelvic lymph node dissection; Robotic surgery

Mesh:

Year:  2017        PMID: 29124406     DOI: 10.1007/s00464-017-5948-4

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  29 in total

1.  Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer (JCOG0212): results from a multicentre, randomised controlled, non-inferiority trial.

Authors:  Shin Fujita; Takayuki Akasu; Junki Mizusawa; Norio Saito; Yusuke Kinugasa; Yukihide Kanemitsu; Masayuki Ohue; Shoichi Fujii; Manabu Shiozawa; Takashi Yamaguchi; Yoshihiro Moriya
Journal:  Lancet Oncol       Date:  2012-05-15       Impact factor: 41.316

2.  Chemotherapy with preoperative radiotherapy in rectal cancer.

Authors:  Jean-François Bosset; Laurence Collette; Gilles Calais; Laurent Mineur; Philippe Maingon; Ljiljana Radosevic-Jelic; Alain Daban; Etienne Bardet; Alexander Beny; Jean-Claude Ollier
Journal:  N Engl J Med       Date:  2006-09-14       Impact factor: 91.245

3.  Radiological findings do not support lateral residual tumour as a major cause of local recurrence of rectal cancer.

Authors:  E Syk; M R Torkzad; L Blomqvist; O Ljungqvist; B Glimelius
Journal:  Br J Surg       Date:  2006-01       Impact factor: 6.939

4.  Lateral lymph node metastasis is a major cause of locoregional recurrence in rectal cancer treated with preoperative chemoradiotherapy and curative resection.

Authors:  Tae Hyun Kim; Seung-Yong Jeong; Dong Hyun Choi; Dae Yong Kim; Kyung Hae Jung; Sung Ho Moon; Hee Jin Chang; Seok-Byung Lim; Hyo Seong Choi; Jae-Gahb Park
Journal:  Ann Surg Oncol       Date:  2007-12-05       Impact factor: 5.344

5.  Clinical implication of additional selective lateral lymph node excision in patients with locally advanced rectal cancer who underwent preoperative chemoradiotherapy.

Authors:  Seok-Byung Lim; Chang Sik Yu; Chan Wook Kim; Yong Sik Yoon; Seong Ho Park; Tae Won Kim; Jong Hoon Kim; Jin Cheon Kim
Journal:  Int J Colorectal Dis       Date:  2013-08-14       Impact factor: 2.571

Review 6.  Extended lymphadenectomy versus conventional surgery for rectal cancer: a meta-analysis.

Authors:  Panagiotis Georgiou; Emile Tan; Nikolaos Gouvas; Anthony Antoniou; Gina Brown; R John Nicholls; Paris Tekkis
Journal:  Lancet Oncol       Date:  2009-09-18       Impact factor: 41.316

7.  The American Urological Association symptom index for benign prostatic hyperplasia as a function of age, volume and ultrasonic appearance of the prostate.

Authors:  M Kojima; Y Naya; W Inoue; O Ukimura; M Watanabe; M Saitoh; H Watanabe
Journal:  J Urol       Date:  1997-06       Impact factor: 7.450

8.  Short-term outcomes after robotic-assisted total mesorectal excision for rectal cancer.

Authors:  Minia Hellan; Casandra Anderson; Joshua D I Ellenhorn; Benjamin Paz; Alessio Pigazzi
Journal:  Ann Surg Oncol       Date:  2007-09-01       Impact factor: 5.344

9.  Outcomes of surgery alone for lower rectal cancer with and without pelvic sidewall dissection.

Authors:  Hirotoshi Kobayashi; Hidetaka Mochizuki; Tomoyuki Kato; Takeo Mori; Shingo Kameoka; Kazuo Shirouzu; Kenichi Sugihara
Journal:  Dis Colon Rectum       Date:  2009-04       Impact factor: 4.585

10.  Selective lateral pelvic lymph node dissection in patients with advanced low rectal cancer treated with preoperative chemoradiotherapy based on pretreatment imaging.

Authors:  Takashi Akiyoshi; Masashi Ueno; Kiyoshi Matsueda; Tsuyoshi Konishi; Yoshiya Fujimoto; Satoshi Nagayama; Yosuke Fukunaga; Toshiyuki Unno; Atsuhiro Kano; Hiroya Kuroyanagi; Masatoshi Oya; Toshiharu Yamaguchi; Toshiaki Watanabe; Tetsuichiro Muto
Journal:  Ann Surg Oncol       Date:  2013-08-21       Impact factor: 5.344

View more
  11 in total

1.  S122: impact of fluorescence and 3D images to completeness of lateral pelvic node dissection.

Authors:  Hye Jin Kim; Gyu-Seog Choi; Jun Seok Park; Soo Yeun Park; Seung Hyun Cho; An Na Seo; Ghuil Suk Yoon
Journal:  Surg Endosc       Date:  2019-05-28       Impact factor: 4.584

Review 2.  Robotics Total Mesorectal Excision Up To the Minute.

Authors:  Homoud Alawfi; Ho Seung Kim; Seung Yoon Yang; Nam Kyu Kim
Journal:  Indian J Surg Oncol       Date:  2020-06-04

3.  Robotic pelvic lymph node dissection for rectal cancer.

Authors:  P Tejedor; F Sagias; A Ahmed; S Naqvi; J S Khan
Journal:  Tech Coloproctol       Date:  2018-11-14       Impact factor: 3.781

4.  Robotic Versus Conventional Laparoscopic Surgery for Colorectal Cancer: A Systematic Review and Meta-Analysis with Trial Sequential Analysis.

Authors:  Ka Ting Ng; Azlan Kok Vui Tsia; Vanessa Yu Ling Chong
Journal:  World J Surg       Date:  2019-04       Impact factor: 3.352

5.  Long-term clinical outcomes of total mesorectal excision and selective lateral pelvic lymph node dissection for advanced low rectal cancer: a comparative study of a robotic versus laparoscopic approach.

Authors:  S H Song; G-S Choi; H J Kim; J S Park; S Y Park; S-M Lee; J A Choi; H A Seok
Journal:  Tech Coloproctol       Date:  2021-02-16       Impact factor: 3.781

6.  Initial experience of preoperative short-course radiotherapy followed by oxaliplatin-based consolidation chemotherapy for locally advanced rectal cancer.

Authors:  Jun Seok Park; Min Kyu Kang; Seung Ho Song; Gyu-Seog Choi; Soo Yeun Park; Hye Jin Kim; Jong Gwang Kim; Byung Woog Kang; Jin Ho Baek; Dong Won Baek; Jae-Chul Kim; Shin-Hyung Park; Seung Hyun Cho; An Na Seo
Journal:  Int J Colorectal Dis       Date:  2021-02-06       Impact factor: 2.571

Review 7.  Robotic-assisted surgery for rectal cancer: Current state and future perspective.

Authors:  Takatoshi Matsuyama; Yusuke Kinugasa; Yasuaki Nakajima; Kazuyuki Kojima
Journal:  Ann Gastroenterol Surg       Date:  2018-09-05

Review 8.  Laparoscopic and robotic lateral lymph node dissection for rectal cancer.

Authors:  Ryota Nakanishi; Tomohiro Yamaguchi; Takashi Akiyoshi; Toshiya Nagasaki; Satoshi Nagayama; Toshiki Mukai; Masashi Ueno; Yosuke Fukunaga; Tsuyoshi Konishi
Journal:  Surg Today       Date:  2020-01-27       Impact factor: 2.549

9.  Extended Lymphadenectomy in Locally Advanced Rectal Cancers: A Systematic Review.

Authors:  Balaji Mahendran; Supriya Balasubramanya; Simone Sebastiani; Sebastian Smolarek
Journal:  Ann Coloproctol       Date:  2021-11-17

10.  Difference in surgical outcomes of rectal cancer by study design: meta-analyses of randomized clinical trials, case-matched studies, and cohort studies.

Authors:  N Hoshino; T Sakamoto; K Hida; Y Takahashi; H Okada; K Obama; T Nakayama
Journal:  BJS Open       Date:  2021-03-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.